ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $54,000 | -20.6% | 12,955 | +0.6% | 0.00% | – |
| Q2 2021 | $68,000 | +15.3% | 12,880 | +0.7% | 0.00% | – |
| Q1 2021 | $59,000 | +34.1% | 12,785 | -5.1% | 0.00% | – |
| Q4 2020 | $44,000 | -2.2% | 13,472 | -1.6% | 0.00% | – |
| Q3 2020 | $45,000 | -11.8% | 13,692 | -9.9% | 0.00% | – |
| Q2 2020 | $51,000 | -13.6% | 15,192 | -2.6% | 0.00% | – |
| Q1 2020 | $59,000 | -47.8% | 15,592 | -17.0% | 0.00% | – |
| Q4 2019 | $113,000 | -16.9% | 18,792 | +3.9% | 0.00% | -100.0% |
| Q3 2019 | $136,000 | -25.3% | 18,092 | +34.1% | 0.00% | 0.0% |
| Q2 2019 | $182,000 | +333.3% | 13,492 | -6.4% | 0.00% | – |
| Q4 2018 | $42,000 | – | 14,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |